| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1600-6143.2004.00672.X |
| P8608 | Fatcat ID | release_p6z4an6hc5ddhjmwfnafhhfefq |
| P698 | PubMed publication ID | 15643991 |
| P5875 | ResearchGate publication ID | 8087423 |
| P50 | author | George Mazariegos | Q42906177 |
| Adriana Zeevi | Q64123938 | ||
| Angus W. Thomson | Q29887918 | ||
| P2093 | author name string | Jorge Reyes | |
| Alan F Zahorchak | |||
| Holly Chapman | |||
| P2860 | cites work | Dendritic cells: emerging pharmacological targets of immunosuppressive drugs | Q35620073 |
| The development of murine plasmacytoid dendritic cell precursors is differentially regulated by FLT3-ligand and granulocyte/macrophage colony-stimulating factor | Q36370212 | ||
| Measurement of Epstein-Barr Virus DNA Loads in Whole Blood and Plasma by TaqMan PCR and in Peripheral Blood Lymphocytes by Competitive PCR | Q37058470 | ||
| Immature dendritic cells generated with low doses of GM-CSF in the absence of IL-4 are maturation resistant and prolong allograft survival in vivo | Q40752701 | ||
| Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells | Q42944333 | ||
| Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen | Q42972592 | ||
| Corticosteroids prevent generation of CD34+-derived dermal dendritic cells but do not inhibit Langerhans cell development | Q44021501 | ||
| Immunomodulatory effects of cyclosporin A on human peripheral blood dendritic cell subsets | Q44326392 | ||
| Circulating human plasmacytoid dendritic cells are highly sensitive to corticosteroid administration | Q44412440 | ||
| Acute graft-versus-host disease and steroid treatment impair CD11c+ and CD123+ dendritic cell reconstitution after allogeneic peripheral blood stem cell transplantation | Q45119325 | ||
| Human peripheral blood contains two distinct lineages of dendritic cells. | Q52174176 | ||
| Immunobiology of dendritic cells | Q29547465 | ||
| Tolerogenic dendritic cells | Q29618755 | ||
| Recruitment of CD1a+ Langerhans cells to the nasal mucosa in seasonal allergic rhinitis and effects of topical corticosteroid therapy | Q31891476 | ||
| Dendritic cells in transplantation--friend or foe? | Q34241103 | ||
| Dendritic cell lineage, plasticity and cross-regulation | Q34295294 | ||
| Origin and differentiation of dendritic cells | Q34460711 | ||
| Mouse and human dendritic cell subtypes | Q34576401 | ||
| Plasmacytoid dendritic cells: do they have a role in immune responses after hematopoietic cell transplantation? | Q35024792 | ||
| Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients | Q35160185 | ||
| Role of plasmacytoid dendritic cells in immunity and tolerance after allogeneic hematopoietic stem cell transplantation | Q35216482 | ||
| Dendritic cells: regulators of alloimmunity and opportunities for tolerance induction | Q35583516 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | dendritic cell | Q506253 |
| immunosuppression | Q1455316 | ||
| P304 | page(s) | 314-322 | |
| P577 | publication date | 2005-02-01 | |
| P1433 | published in | American Journal of Transplantation | Q4744273 |
| P1476 | title | Dendritic cell subset ratio in tolerant, weaning and non-tolerant liver recipients is not affected by extent of immunosuppression | |
| P478 | volume | 5 |
| Q53585469 | Alemtuzumab (Campath-1H) induction therapy and dendritic cells: Impact on peripheral dendritic cell repertoire in renal allograft recipients. |
| Q42234521 | BIOMARKERS OF OPERATIONAL TOLERANCE IN SOLID ORGAN TRANSPLANTATION. |
| Q38080021 | Clinical operational tolerance in liver transplantation: state-of-the-art perspective and future prospects |
| Q36738538 | Clinical tolerance following liver transplantation: long term results and future prospects. |
| Q37843801 | Clinical transplantation tolerance |
| Q88663316 | Contemporary Strategies and Barriers to Transplantation Tolerance |
| Q51364475 | Dendritic cells and regulation of alloimmune responses: relevance to outcome and therapy of organ transplantation. |
| Q37008790 | Dendritic cells, the liver, and transplantation |
| Q42165012 | Donor lung derived myeloid and plasmacytoid dendritic cells differentially regulate T cell proliferation and cytokine production |
| Q26825632 | Dual protective role of HO-1 in transplanted liver grafts: a review of experimental and clinical studies |
| Q37803411 | Finding the right time for weaning off immunosuppression in solid organ transplant recipients |
| Q34927885 | HLA-G level on monocytoid dendritic cells correlates with regulatory T-cell Foxp3 expression in liver transplant tolerance |
| Q37717939 | Heart transplantation: challenges facing the field |
| Q40278618 | Hepatic Infiltrates in Operational Tolerant Patients After Liver Transplantation Show Enrichment of Regulatory T Cells Before Proinflammatory Genes Are Downregulated |
| Q39716447 | Hot-topic debate on tolerance: immunosuppression withdrawal |
| Q37190393 | Human dendritic cells and transplant outcome. |
| Q38199499 | Immune monitoring post liver transplant |
| Q37400370 | Immunologic Basis of Graft Rejection and Tolerance Following Transplantation of Liver or Other Solid Organs |
| Q36485929 | Immunomodulating effects of the anti-viral agent Silibinin in liver transplant patients with HCV recurrence |
| Q33790339 | Immunoregulatory profiles in liver transplant recipients on different immunosuppressive agents. |
| Q80654708 | Impairment of circulating myeloid dendritic cells in immunosuppressed liver transplant recipients |
| Q36501667 | Is clinical tolerance realistic in the next decade? |
| Q37810357 | Liver antigen-presenting cells |
| Q64248277 | Long-Term Signs of T Cell and Myeloid Cell Activation After Intestinal Transplantation With Cellular Rejections Contributing to Further Increase of CD16 Cell Subsets |
| Q46390308 | Long-term medical management of the pediatric patient after liver transplantation: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. |
| Q36738529 | Monitoring tolerance after human liver transplantation |
| Q36738534 | New aspect of immunosuppressive treatment in liver transplantation. How could you induce tolerance in liver transplantation? |
| Q48413245 | Operational tolerance in clinical liver transplantation: emerging developments |
| Q35911564 | Organ-specific differences in achieving tolerance |
| Q82138731 | Plasmacytoid dendritic cells: in vivo regulators of alloimmune reactivity? |
| Q36176628 | Prognostic assays for rejection and tolerance in organ transplantation |
| Q38013048 | Regulatory immune cells in transplantation |
| Q57791877 | The Tor Vergata weaning off immunosuppression protocol in stable HCV liver transplant patients: The updated follow up at 78 months |
| Q37607455 | The immunological monitoring of kidney and liver transplants in adult and pediatric recipients |
| Q28079523 | Tolerance in liver transplantation: Biomarkers and clinical relevance |
| Q35915308 | Tolerance signatures in transplant recipients |
| Q36302853 | Tolerogenic dendritic cells and their applications in transplantation |
| Q35341379 | Tolerogenic dendritic cells and their role in transplantation. |
| Q37683083 | Tolerogenic plasmacytoid DC. |
| Q98222297 | Understanding, predicting and achieving liver transplant tolerance: from bench to bedside |
| Q26783976 | Withdrawal of immunosuppression in liver transplantation and the mechanism of tolerance |
Search more.